Statement Of Cash Flows [Abstract]

Biotage - Filing #678905

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities	10,000,000 SEK	—	—	5,000,000 SEK	—
Interest received, classified as operating activities	9,000,000 SEK	—	—	2,000,000 SEK	—
Cash flows from (used in) operating activities	28 4 SEK	—	—	341,000,000 SEK	—
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities	1 25 SEK	—	—	12,000,000 SEK	—
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities	1,000,000 SEK	—	—	2,000,000 SEK	—
Purchase of property, plant and equipment, classified as investing activities	26,000,000 SEK	—	—	35,000,000 SEK	—
Purchase of intangible assets, classified as investing activities	65,000,000 SEK	—	—	3 5 SEK	—
Cash flows from (used in) investing activities	35,000,000 SEK	—	—	84,000,000 SEK	—
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares	2,000,000 SEK	—	—	– SEK	—
Proceeds from borrowings, classified as financing activities	– SEK	—	—	150,000,000 SEK	—
Repayments of borrowings, classified as financing activities	38,000,000 SEK	—	—	180,000,000 SEK	—
Cash flows from (used in) financing activities	142,000,000 SEK	—	—	13 3 SEK	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	177,000,000 SEK	—	—	124,000,000 SEK	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	24,000,000 SEK	—	—	6,000,000 SEK	—
Cash and cash equivalents	—	594,000,000 SEK	4 41 SEK	—	311,000,000 SEK